Get started

Abbott

Abbott Labs Shakes Off Downtrend, Sets Sights on $142 milestoneIn December 2021, the stock price hit an all-time high near the 142 mark, after which it experienced a significant drop. Following this decline, the price found support around the 90 level and began to recover. Last week, the stock managed to break through the upper boundary of the descending parallel channel, setting the stage for additional upward momentum. An immediate resistance level is noted at the 122 level, and a substantial movement is expected if this level is surpassed.
NYSE:ABTLong
by NaranjCapital
Abbott India Poised for Upside: Targets ₹29,360Abbott India closed the week at ₹28,808, showing signs of strength as it approaches key upside targets of ₹29,360 and ₹29,800. With RSI above 50%, the stock is signaling increased bullish momentum, making it an attractive buy for the upcoming week. The stock has recently corrected over 10% during the previous downturn, creating an opportunity for a rebound. Investors looking for a return of over 3% may find this an ideal entry point. The major support level is at ₹28,093, providing a solid foundation for any potential pullbacks. As long as the stock remains above this support and RSI continues to stay above 50, the bullish trend is expected to persist. This setup offers a favorable risk-reward ratio, making it a great opportunity for those looking to capitalize on Abbott India’s upside potential next week.
NSE:ABBOTINDIALong
by Sudhir-Sirohi
ABT Abbott Laboratories Options Ahead of EarningsIf you haven`t sold the regional top on ABT: Nor reentered this fantastic dip: Then analyzing the options chain and the chart patterns of ABT Abbott Laboratories prior to the earnings report this week, I would consider purchasing the 115usd strike price at the money Calls with an expiration date of 2024-2-16, for a premium of approximately $2.26. The chart is overextended and the RSI overbought, but I think there is one more leg to go before a correction. If these options prove to be profitable prior to the earnings release, I would sell at least half of them.
NYSE:ABTLong
by TopgOptions
1
TRADE SETUP_WAVE V IN ABBOT_15-20% MOVEAbbott India Ltd. is seen coming out of a fourth wave triangle and is expected to have completed wave i of V. The stock had remained in a 3month long correction during the fourth wave between Aug and Nov. The stock is currently close to the support area of 23000 and is expected to settle and reverse from around here. The final projected target for fifth wave completion comes in at around 27.5K-29K zone. Note*-The views expressed are personal observations/opinions. Kindly do your own analysis before taking up any trading positions.
NSE:ABBOTINDIALong
by neeraj_2_sharma
1
ABT Abbott Laboratories Options Ahead of EarningsIf you haven`t bought ABT here: or sold it here: Then analyzing the options chain and the chart patterns of ABT Abbott Laboratories prior to the earnings report this week, I would consider purchasing the 91usd strike price Calls with an expiration date of 2023-10-27, for a premium of approximately $3.15. If these options prove to be profitable prior to the earnings release, I would sell at least half of them. Looking forward to read your opinion about it.
NYSE:ABTLong
by TopgOptions
2
Abbott Laboratories in a bull flag.Abbott Labratories - 30d expiry - We look to Buy a break of 109.51 (stop at 106.31) The primary trend remains bullish. This stock has seen good sales growth. Expect trading to remain mixed and volatile. 109.34 has been pivotal. Posted a bullish Flag formation. A break of 109.34 is needed to confirm the outlook. The bias is to break to the upside. Our profit targets will be 117.51 and 119.51 Resistance: 108.50 / 109.34 / 112.95 Support: 106.80 / 105.96 / 104.00 Please be advised that the information presented on TradingView is provided to Vantage (‘Vantage Global Limited’, ‘we’) by a third-party provider (‘Everest Fortune Group’). Please be reminded that you are solely responsible for the trading decisions on your account. There is a very high degree of risk involved in trading. Any information and/or content is intended entirely for research, educational and informational purposes only and does not constitute investment or consultation advice or investment strategy. The information is not tailored to the investment needs of any specific person and therefore does not involve a consideration of any of the investment objectives, financial situation or needs of any viewer that may receive it. Kindly also note that past performance is not a reliable indicator of future results. Actual results may differ materially from those anticipated in forward-looking or past performance statements. We assume no liability as to the accuracy or completeness of any of the information and/or content provided herein and the Company cannot be held responsible for any omission, mistake nor for any loss or damage including without limitation to any loss of profit which may arise from reliance on any information supplied by Everest Fortune Group.
NYSE:ABTLong
by VantageMarkets
ABT Abbott Laboratories Options Ahead of EarningsIf you haven`t bought ABT here: Then analyzing the options chain of ABT Abbott Laboratories prior to the earnings report this week, I would consider purchasing the 108usd strike price in the money Puts with an expiration date of 7/21/2023, for a premium of approximately $2.55. If these options prove to be profitable prior to the earnings release, I would sell at least half of them. Looking forward to read your opinion about it.
NYSE:ABTShort
by TopgOptions
Risky Move on Abbott. ABTA collection of confluent clues. 0.786 retrace on A, quadruple pincers, low volume, RSX OBOS probably peaking, P/C ratio momentally toward green. Swing low within significant count of swing high (? Fib 1:1 ratio timewise). If it doesn't swing, stop loss is close and will not break this bank. We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in green with invalidation in red. Confirmation level, where relevant, is a pink dotted, finite line. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statistically likely levels that the market will go to. Having said that, the market will always do what it wants and always has a mind of its own. Therefore, none of this is financial advice, so do your own research and rely only on your own analysis. Trading is a true one man sport. Good luck out there and stay safe.
NYSE:ABTLong
by Rykin_Capital
Lagging Ending Diagonal on Abbott. ABTWe are probably at the end of this zigzag in that we are forming what appears to be a lagging diagonal. These tend to be final in a local correction, so it may be that this is the last short I will be putting on this one for a while. We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in purple with invalidation in red. Confirmation level, where relevant, is a pink dotted, finite line. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statistically likely levels that the market will go to. Having said that, the market will always do what it wants and always has a mind of its own. Therefore, none of this is financial advice, so do your own research and rely only on your own analysis. Trading is a true one man sport. Good luck out there and stay safe.
NYSE:ABTShort
by Rykin_Capital